Advertisement

Antidepressants and Anticonvulsants

  • Melinda AquinoEmail author
Chapter

Abstract

Antidepressants and anticonvulsants are widely used to treat a wide variety of pain disorders.

These medications have significant utility not only in the treatment of neuropathic pain but also in the management of nociceptive and mixed pain types, as well. Caution must be exercised when prescribing these compounds, as many have significant side effects and drug interactions, to which the elderly are particularly susceptible.

Keywords

Antidepressants Anticonvulsants Gabapentinoids Tricyclic Serotonin reuptake inhibitor Norepinephrine reuptake inhibitor Antiepileptic drug (AED) 

References

  1. 1.
    DeBattista C. Antidepressant agents. In: Katzung BG, Trevor AJ, editors. Basic & clinical pharmacology. 13th ed. New York: McGraw-Hill; 2015.Google Scholar
  2. 2.
    Verdu B. Antidepressants for the treatment of chronic pain. Drugs. 2008;68(18):2611–32.CrossRefPubMedGoogle Scholar
  3. 3.
    Kasper S, Pail G. Milnacipran: a unique antidepressant? Neuropsychiatr Dis Treat. 2010;6(Suppl I):23–31.  https://doi.org/10.2147/NDT.S11777.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Shelton R. Serotonin norepinephrine reuptake inhibitors: similarities and differences. Prim Psychiatry. 2009;15:5(Suppl 4):25–35.Google Scholar
  5. 5.
    Roe M, et al. Pharmacology in the management of chronic pain. Anaesth Intensive Care Med. 2016;17(11):548–51.CrossRefGoogle Scholar
  6. 6.
    Derry S, Gill D, Phillips T, Moore RA. Milnacipran for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(3):Art. No.: CD008244.  https://doi.org/10.1002/14651858.CD008244.pub2.
  7. 7.
    Celikyurt IK, Mutlu O, Ulak G. Serotonin Noradrenaline Reuptake Inhibitors (SNRIs), Effects of antidepressants, Dr. Ru-Band Lu (Ed.), InTech, 2012.  https://doi.org/10.5772/37999.Google Scholar
  8. 8.
    Selke KJ, Dhar G, Cohn JM. Takotsubo cardiomyopathy associated with titration of duloxetine. Tex Heart Inst J. 2011;38(5):573–6.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain. 2010;23(2):99–108.  https://doi.org/10.3344/kjp.2010.23.2.99.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Aronoff GM, Gallagher RM, Patel JG. Pharmacological management of chronic pain: a review. In: Tollison CD, et al., editors. Practical pain management. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2002.Google Scholar
  11. 11.
    Perruca E. The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia. 1999;40(Suppl):S7–S13.CrossRefGoogle Scholar
  12. 12.
    Sidhu HS, Sadhotra A. Current status of the new antiepileptic drugs in chronic pain. Front Pharmacol. 2016;7:276.  https://doi.org/10.3389/fphar.2016.00276.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ryder S-A, Stannard CF. Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs. Contin Educ Anaesth Crit Care Pain. 2005;5(1):18–21.CrossRefGoogle Scholar
  14. 14.
    Rose MA, Kam PCA. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57:451–62.CrossRefPubMedGoogle Scholar
  15. 15.
    Dinakar P. Principles in pain management. In: Daroff RB, Jankovic J, et al., editors. Bradley’s neurology in clinical practice. 7th ed. Philadelphia: Elsevier Health Sciences; 2015.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Montefiore Medical CenterAlbert Einstein College of MedicineBronxUSA

Personalised recommendations